BGC20-1531, a novel, potent and selective prostanoid EP receptor antagonist: a putative new treatment for migraine headache. - Wikidata - awgldk - TriplyDB

BGC20-1531, a novel, potent and selective prostanoid EP receptor antagonist: a putative new treatment for migraine headache.

BGC20-1531, a novel, potent and selective prostanoid EP receptor antagonist: a putative new treatment for migraine headache.

http://www.wikidata.org/entity/Q37230998

about

Non-steroidal anti-inflammatory drugs and cognitive function: are prostaglandins at the heart of cognitive impairment in dementia and delirium?E-type prostanoid receptor 4 (EP4) in disease and therapy The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors Prostanoid receptor antagonists: development strategies and therapeutic applications An update on the blood vessel in migraine The pharmacological effect of BGC20-1531, a novel prostanoid EP4 receptor antagonist, in the prostaglandin E2 human model of headache.In vitro and in vivo characterization of PF-04418948, a novel, potent and selective prostaglandin EP₂ receptor antagonist.Prostaglandins in cancer cell adhesion, migration, and invasion New drugs for migraine Novel prostaglandin receptor modulators--part II: EP receptor modulators; a patent review (2002 - 2012).Prostaglandin EP4 antagonists.COX inhibitors for the treatment of migraine.Investigational drugs targeting the prostaglandin E2 signaling pathway for the treatment of inflammatory pain.N-acylsulfonamides: Synthetic routes and biological potential in medicinal chemistry.Advances in drug development for acute migraine.Mapping PTGERs to the Ovulatory Follicle: Regional Responses to the Ovulatory PGE2 Signal.Acute migraine therapy: new drugs and new approaches.Functional and molecular characterization of prostaglandin E2 dilatory receptors in the rat craniovascular system in relevance to migraine.Capsaicin-induced vasodilatation in human nasal vasculature is mediated by modulation of cyclooxygenase-2 activity and abrogated by sulprostone.Prostaglandin E2 induces immediate migraine-like attack in migraine patients without aura

P2860

Q26822022-015E27E6-32D5-4EB9-9120-DACAE4977B28 Q26851156-0392B819-19E2-4BF2-B377-EB3A76F9A1E7 Q30486707-028003BA-D2EF-434F-A32D-2754B004737F Q33485483-E80863B5-7AC8-49A5-B948-0219845D8012 Q33880507-D4DFF588-C0BC-4089-9EE7-EE50999F3ED0 Q35214562-618988C3-324C-4490-97AA-200DD2CF7284 Q35636109-2A8303C1-91EF-4324-AB23-302EF3BC8531 Q35821653-202DA32A-498F-4820-A410-1AEDC1AC6A40 Q36332611-E1CE8EF9-0D4D-4C9A-8265-57EC0166C748 Q38071643-BFBB6B6D-9C17-46D7-8167-845B441C0C85 Q38162977-14343C4D-5862-4D3B-B667-67BE2C827941 Q38227997-05126C8D-F89A-47DE-AA8C-DDD6B0C72E15 Q39007494-0850CAE5-7982-4F57-B01D-AD130DFA005E Q39386218-C4E2E0AF-B2B3-4D7F-86E5-AF6B12994839 Q39527265-5471659E-AC43-486B-81CF-39D666B6AECA Q41132032-95719379-A118-4F70-85A6-65A40E78ED1C Q41642373-7D2135E6-8542-467A-B991-0F63804B1272 Q42936119-60410A5E-C525-4E8D-80D7-1A636F5D69CB Q49064177-478493F7-639E-40F5-A75A-1C3CDE46B76C Q57023979-8CB645FE-020E-4B90-A337-0AA154306722

P2860

BGC20-1531, a novel, potent and selective prostanoid EP receptor antagonist: a putative new treatment for migraine headache.

http://www.wikidata.org/entity/Q37230998

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 19 January 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

BGC20-1531, a novel, potent an ...... eatment for migraine headache.

@en

BGC20-1531, a novel, potent an ...... eatment for migraine headache.

@nl

type

label

BGC20-1531, a novel, potent an ...... eatment for migraine headache.

@en

BGC20-1531, a novel, potent an ...... eatment for migraine headache.

@nl

prefLabel

BGC20-1531, a novel, potent an ...... eatment for migraine headache.

@en

BGC20-1531, a novel, potent an ...... eatment for migraine headache.

@nl

P1433

Q37230998-F0D4E195-C355-4C8F-8794-697BFF0F31FC

P1476

Q37230998-71369A9B-F2A9-4AE2-B85D-1166A7E9876F

P2093

Q37230998-046E11FA-5BC7-4566-A4D3-DFA549771872

Q37230998-08627833-B687-465C-9B40-A87A2CEC4301

Q37230998-40F185EE-3A07-4DE9-A861-00B804AF5341

Q37230998-4AA7B5FE-9DFB-4DA0-BA48-E884D249D20C

Q37230998-5BDEF809-D447-45DC-8E9A-22B7BCDCDA26

Q37230998-7A7CE679-1A59-4BC6-89BB-1A44B024DBF7

Q37230998-8B11E457-37D8-4E31-B0E5-AE08ADA72559

Q37230998-A2C820DB-0F00-4830-A014-33A1AF1942ED

Q37230998-BBBEF15D-EF9B-405E-898E-0D956EF7BAAD

Q37230998-F16CC142-96A0-41A9-A713-8BDA684D9F38

P2860

Q37230998-04485060-02C9-4CB4-BD44-03E4417D5403

Q37230998-0B7E4279-8D63-4EF8-A0EB-DEE817C6D89A

Q37230998-0FDEB873-8BE8-4385-AA8C-F2457923F7CE

Q37230998-2323B2E8-5081-4B10-98CA-A7C6D28F3AEA

Q37230998-2345BA4B-D1A9-4B96-ADE4-00D331514D60

Q37230998-27B139AD-A42F-417C-9355-B695DBB81ADF

Q37230998-288F3258-9AA7-4D44-BDB0-594FFEA83267

Q37230998-2A0BB89F-A640-452B-9F51-B126E0C9EA66

Q37230998-2D290098-E599-4130-B601-450B9DE6F8E8

Q37230998-33A624F7-C90E-4E7F-B875-B7E8B8366A8B

P304

Q37230998-7F854D25-D9F8-4629-807A-5C5DC0E8EEC5

P31

Q37230998-DACDA23A-14A3-497F-A164-A88F3971EE80

P356

Q37230998-1328EDDE-52AD-4A3B-B736-66604DD72CB4

P407

Q37230998-502D0FEA-8F5E-43EA-B5AB-3866AF64C5D6

P433

Q37230998-CF20ED24-D8B9-415D-B737-9E655AF4DF22

P478

Q37230998-4FC0464D-250C-42AA-8BEE-27AC7D3DF3A4

P577

Q37230998-10C8F477-678F-40F3-AA7F-C5ECC6A59A7D

P5875

Q37230998-740E7B75-1055-440E-913B-9BCC06BD6CEF

P698

Q37230998-DB8AF572-96E5-4CDD-81C6-5563A77383B9

P921

Q37230998-1CFB1CAB-1D4C-43F6-B9EE-D351AA41FCB5

Q37230998-B4551480-4407-47E7-86E0-788211AF5CDE

P932

Q37230998-65053231-6982-4685-81BE-23E5BF34FAC5

P356

J.1476-5381.2009.00027.X

P1433

British Journal of Pharmacology

P1476

BGC20-1531, a novel, potent an ...... eatment for migraine headache.

@en

P2093

A W Oxford

http://www.w3.org/2001/XMLSchema#string

C Routledge

http://www.w3.org/2001/XMLSchema#string

D E Clark

http://www.w3.org/2001/XMLSchema#string

G Fenton

http://www.w3.org/2001/XMLSchema#string

K A Maubach

http://www.w3.org/2001/XMLSchema#string

K L Clark

http://www.w3.org/2001/XMLSchema#string

P M Lockey

http://www.w3.org/2001/XMLSchema#string

R A Coleman

http://www.w3.org/2001/XMLSchema#string

R J Davis

http://www.w3.org/2001/XMLSchema#string

R M Hagan

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of the prostanoid receptor types involved in mediating calcitonin gene-related peptide release from cultured rat trigeminal neurones

Effect of (S)-4-(1-(5-chloro-2-(4-fluorophenyoxy)benzamido)ethyl) benzoic acid (CJ-42794), a selective antagonist of prostaglandin E receptor subtype 4, on ulcerogenic and healing responses in rat gastrointestinal mucosa

International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes

GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro

Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation

Prostaglandin receptor subtypes, EP3C and EP4, mediate the prostaglandin E2-induced cAMP production and sensitization of sensory neurons

Adaptive cytoprotection mediated by prostaglandin I(2) is attributable to sensitization of CRGP-containing sensory nerves

The roles of prostaglandin E receptor subtypes in the cytoprotective action of prostaglandin E2 in rat stomach

Some quantitative uses of drug antagonists

Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials.

P304

316-327

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1476-5381.2009.00027.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

156

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23802300

http://www.w3.org/2001/XMLSchema#string

P698

19154437

http://www.w3.org/2001/XMLSchema#string

P921

migraine disorder

P932

2697835

http://www.w3.org/2001/XMLSchema#string